Medtronic completes separation of MiniMed Group
Medtronic finishes spinning off its diabetes division. The CEO highlights strategic focus shifts for both independent entities moving forward.
See the latest news and media coverage for Medtronic. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device and health technology company
medtronic.comLast updated
In short: Medtronic posted strong Q1 FY2027 results, raised guidance, and completed its MiniMed separation amid recalls and legal challenges.
Medtronic finishes spinning off its diabetes division. The CEO highlights strategic focus shifts for both independent entities moving forward.
The oversubscribed offer allows Medtronic to acquire all remaining MiniMed shares. Proration applies, with final results expected on October 14.
The company offers a fixed ratio of 4.5939 MiniMed shares per Medtronic share, expiring October 9, 2026.
The company secured regulatory clearances for Affera Prism-2 mapping and PulseSelect proximity indicator systems.
Medtronic officially split-off MiniMed to focus on its core businesses. Investors wanted more of the stock than they had to offer.
Two women with diabetes on Monday accused Medtronic of knowingly selling insulin pumps with a known defect that can deliver the wrong amount of insulin...
Medtronic recalled Bravo CF capsule devices after reports of serious injuries. Lawyers are investigating injuries and potential lawsuits.
Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of...
Track Medtronic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Medtronic and other trending companies.